Page last updated: 2024-11-05

benzyl bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzyl bromide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzyl bromide : A member of the class of benzyl bromides that is toluene substituted on the alpha-carbon with bromine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7498
CHEMBL ID1085946
CHEBI ID59858
SCHEMBL ID1066
MeSH IDM0116289

Synonyms (90)

Synonym
AKOS009031551
.omega.-bromotoluene
wln: e1r
nsc-8041
.alpha.-bromotoluene
benzyl bromide
nsc8041
toluene, .alpha.-bromo-
benzene, (bromomethyl)-
bromophenylmethane
100-39-0
(bromomethyl)benzene
1-bromotoluene
inchi=1/c7h7br/c8-6-7-4-2-1-3-5-7/h1-5h,6h
toluene,alpha-bromo
NCGC00091670-01
alpha-bromotoluene
nsc 8041
ccris 5980
ai3-15300
un1737
toluene, alpha-bromo-
hsdb 369
einecs 202-847-3
cyclite
benzyl bromide, reagent grade, 98%
benzene, bromomethyl-
B0411
phenylmethyl bromide
CHEBI:59858 ,
bromomethylbenzene
CHEMBL1085946 ,
bdbm50318512
NCGC00091670-02
benzylbromide
bnbr
benzyl bromide [un1737] [poison]
xr75bs721d ,
unii-xr75bs721d
ec 202-847-3
NCGC00257572-01
cas-100-39-0
dtxsid8024658 ,
dtxcid304658
tox21_200018
28807-97-8
a-bromotoluene
FT-0622767
gtpl6294
BP-21025
SCHEMBL1066
benzyl bromide [mi]
benzyl bromide [hsdb]
bromomethly-benzene
c6h5ch2br
bn-br
benzyl bromid
(bromo methyl)benzene
phch2br
bromomethyl-benzene
1-(bromomethyl)benzene
benzyl-bromide
benzyibromide
benzylbromid
(bromomethyl) benzene
benyl bromide
1-bromomethylbenzene
1-bromomethyl-benzene
benzyi bromide
bromomethyl benzene
4-bromomethyl-benzene
benzyl bromine
un 1737
bromotoluene, .alpha.
mfcd00000172
J-000123
Q416113
benzyl-2,3,4,5,6-d5 bromide
55514-87-9
AMY21948
(bromomethyl)benzene;alpha-bromotoluene
BCP31679
benzyl bromide |a-bromotoluene
(bromomethyl)benzene// benzyl bromide
benzylbromide-13c6
alpha-bromo-toluene
bromotoluene, alpha
bromuro de bencilo
omega-bromotoluene
(bromophenyl)methane

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
lachrymatorAny substance that stimulates the corneal nerves in the eves to cause tears.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzyl bromidesCompounds containing a (bromomethyl)benzene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
RAR-related orphan receptor gammaMus musculus (house mouse)Potency22.15400.006038.004119,952.5996AID1159521
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.01000.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency70.05700.003041.611522,387.1992AID1159552
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency50.11870.023723.228263.5986AID588543
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)12.00000.00033.166210.0000AID482136
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1346556Human TRPA1 (Transient Receptor Potential channels)2009FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Apr, Volume: 23, Issue:4
Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases.
AID482136Activation of human TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (9.43)18.7374
1990's2 (3.77)18.2507
2000's23 (43.40)29.6817
2010's18 (33.96)24.3611
2020's5 (9.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 64.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index64.31 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index105.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (64.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (98.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]